Kathryn Peterson, MD is an Associate Professor of Gastroenterology at University of Utah Health. She is certified by the American Board of Internal Medicine.

Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including Eosiniphilic Esophagitis, Barrett’s Esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by a residency and a fellowship at the University of Utah and a masters program in Epidemiology at Harvard University.

BOARD CERTIFICATION AND ACADEMIC INFORMATION

Academic DepartmentsInternal Medicine - Associate Professor (Clinical)
Dermatology - Adjunct Assistant ProfessorAcademic DivisionsGastroenterologyBoard CertificationAmerican Board of Internal Medicine (Sub: Gastroenterology)

RESEARCH INTERESTS

• Barrett's Esophagus

• Endoscopy

• Eosinophilic Esophagitis

• Esophageal Diseases

• Gastroenterology

• GI Motility

• Inflammatory Bowel Disease/Crohn's/Ulcerative Colitis

EDUCATION HISTORY

Graduate Training: Harvard University
Epidemiology - M.Sci.

Fellowship: University of Utah School of Medicine
Gastroenterology - Fellow

Residency: University of Utah School of Medicine
Internal Medicine - Resident

Internship: University of Utah School of Medicine
Internal Medicine - Intern

Professional Medical: University of Texas Southwestern
Medicine - M.D.

Undergraduate: Texas Tech University
Molecular Biology - B.S.

Undergraduate: University of Delaware

SELECTED PUBLICATIONS - JOURNAL ARTICLES

Journal Article

1. Peterson KA, Gleich GJ, Limaye NS, Crispin H, Robson J, Fang J, Saffari H, Clayton F, Leiferman KM (2019). Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Dis Esophagus, 32(11).

2. Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A (2019). Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. (Epub ahead of print) Gastroenterology.

3. Youngblood BA, Brock EC, Leung J, Falahati R, Bochner BS, Rasmussen HS, Peterson K, Bebbington C, Tomasevic N (2019). Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight, 4(19).

4. McClain A, OGorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson J (2019). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. (Epub ahead of print) Clin Gastroenterol Hepatol.

5. Robson J, Korgenski K, Parsons K, McClain A, Barbagelata C, Allen-Brady K, Patel R, OGorman M, Peterson K, Guthery S (2019). Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(2), e49-e53.

6. Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, OGorman M, Guthery S, Bennett-Murphy L (2019). Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(1), 57-60.

7. Siebermair J, Suksaranjit P, McGann CJ, Peterson KA, Kheirkhahan M, Baher AA, Damal K, Wakili R, Marrouche NF, Wilson BD (2019). Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging. J Cardiovasc Electrophysiol, 30(4), 550-556.

8. Robson J, OGorman M, McClain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery S (2018). Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clin Gastroenterol Hepatol, 17(1), 107-114.e1.

9. Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K (2017). CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome. Inflamm Bowel Dis, 24(7), 1539-1546.

10. Laing P, Bress AP, Fang J, Peterson K, Adler DG, Gawron AJ (2017). Trends in diagnoses after implementation of the Chicago classification for esophageal motility disorders (V3.0) for high-resolution manometry studies. Dis Esophagus, 30(12), 1-6.

11. Martin L, Mullaney S, Peche W, Peterson K, Chan S, Morton R, Wan Y, Zhang C, Presson AP, Emery B, Aston K, Jenkins T, Carrell D, Hotaling J (2017). Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study. Urology, 107, 114-119.

12. Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson K (2017). Oesophageal disease in systemic sclerosis: does heritability play a role? Clin Exp Rheumatol, 35 Suppl 106(4), 86-88.

13. Allred D, Frech TM, McComber C, Peterson K, Ortiz G, McNeill C, Broadbent L, Elorreaga N, Miller T, Scholand MB (2019). Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team. J Med Pract Manage, 32(6), 413-416.

14. Peterson K, Firszt R, Fang J, Wong J, Smith KR, Brady KA (2016). Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study. Am J Gastroenterol, 111(7), 926-32.

15. Padia R, Curtin K, Peterson K, Orlandi RR, Alt J (2016). Eosinophilic esophagitis strongly linked to chronic rhinosinusitis. Laryngoscope, 126(6), 1279-83.

16. Saffari H, Kennedy A, Peterson KA, Gleich GJ, Pease LF 3rd (2015). Non-invasive ultrasound to identify eosinophil granule proteins in eosinophilic esophagitis. Ultrasound Med Biol, 41(3), 884-9.

17. Peterson KA, Boynton KK (2013). Which patients with eosinophilic esophagitis (EoE) should receive elemental diets versus other therapies? Curr Gastroenterol Rep, 16(1), 364.

18. Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Standards of Practice Committee American Society for Gastrointestinal Endoscopy (2003). Tissue sampling and analysis. Gastrointest Endosc, 57(7), 811-6.

19. Faigel DO, Baron TH, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Waring JP, Fanelli RD, Wheeler-Harbaugh J, Standards Practice Committe American Society for Gastrointestinal Endoscopy (2002). Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc, 56(5), 613-7.

Editorial

1. Gupta SK, Falk GW, Aceves SS, Chehade M, Collins MH, Dellon ES, Gonsalves N, Hirano I, Mukkuda VA, Peterson KA, Spergel J, Yang GY, Furuta GT, Rothenberg ME, Consortium of Eosinophilic Gastrointestinal Disease Researchers CEGIR (2018). Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration. Gastroenterology, 156(4), 838-842.

Letter

1. May Maestas M, Perry KD, Smith K, Firszt R, Allen-Brady K, Robson J, Joy E, Peterson K (2019). Food impactions in Eosinophilic esophagitis and acute exposures to fine particulate pollution. [Letter to the editor]. Allergy.

Patent

1. Pease LF, Saffari H, Gleich GJ, Leiferman KM, Peterson KA, Condie RM (2017). Methods for diagnosing and monitoring eosinophilic esophagitis. U.S. Patent No. 10,376,602. Washington, D.C.:U.S. Patent and Trademark Office.

2. Pease LF, Saffari H, Gleich GJ, Leiferman KM, Peterson KA, Condie RM (2013). Methods for diagnosing and monitoring eosinophilic esophagitis. U.S. Patent No. 9,789,212. Washington, D.C.:U.S. Patent and Trademark Office.